The CTNG testing market is projected to be worth USD 1.8 billion in 2024. The market is anticipated to reach USD 3.9 billion by 2034. The market is further expected to surge at a CAGR of 8.0% during the forecast period 2024 to 2034.
Key Market Trends and Highlights
The expansion of healthcare infrastructure, particularly in emerging economies, creates opportunities for increased access to CTNG testing services, leading to market expansion.
| Attributes | Key Insights |
|---|---|
| CTNG Testing Market Estimated Size in 2024 | USD 1.8 billion |
| Projected Market Value in 2034 | USD 3.9 billion |
| Value-based CAGR from 2024 to 2034 | 8.0% |
The scope for CTNG testing rose at a 10.2% CAGR between 2019 and 2023. The global market is anticipated to grow at a moderate CAGR of 8.0% over the forecast period 2024 to 2034.
The CTNG testing Market witnessed steady growth during the historical period, driven by factors such as increasing awareness about STIs, advancements in diagnostic technologies, and expansion of healthcare infrastructure.
Significant advancements in CTNG testing technologies, including the introduction of multi parameter CT/NG NAATs and point of care testing solutions, enhanced the accuracy, sensitivity, and accessibility of diagnostic tests.
The rising incidence of chlamydia and gonorrhea infections globally, coupled with the emergence of antibiotic resistant strains, underscored the need for effective screening and detection methods, driving market demand.
The forecast period is expected to witness continued technological innovations in CTNG testing, including the development of next generation molecular assays, advanced point of care devices, and integrated diagnostic platforms, driving market expansion.
The increasing demand for point of care testing solutions for STIs, driven by the need for rapid and convenient diagnostics in diverse healthcare settings, is expected to fuel market growth during the forecast period.
The expansion of telemedicine platforms and remote testing services is anticipated to facilitate broader access to CTNG testing, particularly in underserved rural areas and resource limited settings, contributing to market expansion.
Increasing awareness about sexually transmitted infections, including chlamydia and gonorrhea, among the population drives the demand for CTNG testing.
The cost associated with CTNG testing procedures, including diagnostic kits, laboratory equipment, and personnel training, can be prohibitive for healthcare providers and patients, hindering widespread adoption and accessibility.
The below table showcases revenues in terms of the top 5 leading countries, spearheaded by Korea and the United Kingdom. The countries are expected to lead the market through 2034.
| Countries | Forecast CAGRs from 2024 to 2034 |
|---|---|
| The United States | 8.3% |
| The United Kingdom | 9.3% |
| Japan | 9.0% |
| China | 8.7% |
| Korea | 9.8% |
The CTNG testing market in the United States expected to expand at a CAGR of 8.3% through 2034. The country has seen a rise in the prevalence of chlamydia and gonorrhea infections, particularly among sexually active individuals and high risk populations, driving the demand for CTNG testing services to address the public health burden of these STIs.
Stringent regulatory requirements set by organizations such as the Food and Drug Administration mandate the need for comprehensive CTNG testing as part of regulatory approvals for medical devices, diagnostics, and pharmaceutical products, fostering market growth.
The CTNG testing market in the United Kingdom is anticipated to expand at a CAGR of 9.3% through 2034.
The implementation of national screening programs, such as the National Chlamydia Screening Program and the National Gonorrhea Screening Programme, promotes routine CTNG testing among sexually active individuals, contributing to increased testing rates and early detection of infections.
Government funding and support for STI prevention, control, and screening initiatives, including investments in sexual health services and public health campaigns, drive the implementation of CTNG testing services and raise public awareness about the importance of STI screening and treatment.
CTNG testing trends in China are taking a turn for the better. An 8.7% CAGR is forecast for the country from 2024 to 2034.
The expansion of healthcare infrastructure in China, including the establishment of sexual health clinics, community health centers, and primary care facilities, facilitates access to CTNG testing services for individuals seeking sexual health care, particularly in urban and rural areas.
Increasing awareness about STIs and sexual health issues, driven by educational initiatives, media campaigns, and community outreach programs, encourages individuals to seek CTNG testing services and promotes safe sexual practices, reducing the spread of STIs.
The CTNG testing market in Japan is poised to expand at a CAGR of 9.0% through 2034. Ongoing advancements in CTNG testing technologies, including nucleic acid amplification tests, molecular assays, and point of care testing devices, enhance the accuracy, sensitivity, and accessibility of testing services, driving market adoption and utilization.
Increased investments by private sector companies in STI diagnostics and healthcare services, coupled with market liberalization policies, stimulate competition, innovation, and market growth in the market.
The CTNG testing market in Korea is anticipated to expand at a CAGR of 9.8% through 2034.
The emergence of antibiotic resistant strains of chlamydia and gonorrhea in Korea highlights the importance of early detection and appropriate treatment, driving the demand for CTNG testing services to guide therapeutic decisions and prevent the spread of drug resistant infections.
Increasing emphasis on sexual health education in schools, universities, and community organizations raises awareness about STIs, promotes safe sexual practices, and encourages regular STI screening among young people and at risk populations, driving the demand for CTNG testing services.
The below table highlights how assays and kits segment is projected to lead the market in terms of product, and is expected to account for a CAGR of 7.7% through 2034. Based on test type, the laboratory segment is expected to account for a CAGR of 7.5% through 2034.
| Category | CAGR from 2024 to 2034 |
|---|---|
| Assays and Kits | 7.7% |
| Laboratory | 7.5% |
Based on product, the assays and kits segment is expected to continue dominating the CTNG testing market. Ongoing advancements in assay and kit technologies, including nucleic acid amplification tests, polymerase chain reaction, and loop mediated isothermal amplification, enhance the sensitivity, specificity, and speed of CTNG detection, driving demand for assay and kit products.
Assays and kits offer high levels of accuracy and reliability in detecting chlamydia and gonorrhea infections, making them essential tools for healthcare providers and laboratories conducting routine screening, diagnosis, and surveillance programs.
Assays and kits are designed to be user friendly, with standardized protocols and procedures that simplify sample collection, processing, and interpretation, enabling healthcare professionals to perform CTNG testing efficiently in diverse clinical and laboratory settings.
In terms of test type, the laboratory segment is expected to continue dominating the CTNG testing market, attributed to several key factors. Laboratory based tests offer high levels of accuracy and precision in detecting chlamydia and gonorrhea infections, making them the gold standard for diagnosis and confirmation of STIs.
Laboratories have the infrastructure, equipment, and expertise to perform comprehensive CTNG testing, including nucleic acid amplification tests, culture based methods, and antimicrobial susceptibility testing, enabling thorough assessment and characterization of STI pathogens.
Laboratories offer specialized testing services, such as genotyping, serotyping, and molecular epidemiology, to identify strain variations, antimicrobial resistance patterns, and transmission dynamics of chlamydia and gonorrhea pathogens, facilitating targeted treatment and public health interventions.
The competitive landscape of the CTNG testing market is characterized by the presence of several established players, emerging companies, and innovative startups competing to gain market share and meet the growing demand for accurate, reliable, and accessible testing solutions for chlamydia and gonorrhea infections.
Company Portfolio
| Attribute | Details |
|---|---|
| Estimated Market Size in 2024 | USD 1.8 billion |
| Projected Market Valuation in 2034 | USD 3.9 billion |
| Value-based CAGR 2024 to 2034 | 8.0% |
| Forecast Period | 2024 to 2034 |
| Historical Data Available for | 2019 to 2023 |
| Market Analysis | Value in USD Billion |
| Key Regions Covered | North America; Latin America; Western Europe; Eastern Europe; South Asia and Pacific; East Asia; The Middle East & Africa |
| Key Market Segments Covered | Product, Test Type, Technology, Region |
| Key Countries Profiled | The United States, Canada, Brazil, Mexico, Germany, France, France, Spain, Italy, Russia, Poland, Czech Republic, Romania, India, Bangladesh, Australia, New Zealand, China, Japan, South Korea, GCC countries, South Africa, Israel |
| Key Companies Profiled | F. Hoffmann-La Roche Ltd.; Hologic Inc.; Thermo Fisher Scientific Inc.; Abbott Laboratories; Bio-Rad Laboratories Inc.; Siemens Healthineers AG; Danaher; Becton, Dickinson and Company; bioMérieux SA |
Table 1: Global Market Value (US$ Million) Forecast by Region, 2019 to 2034
Table 2: Global Market Value (US$ Million) Forecast by Product, 2019 to 2034
Table 3: Global Market Value (US$ Million) Forecast by Test Type, 2019 to 2034
Table 4: Global Market Value (US$ Million) Forecast by Technology, 2019 to 2034
Table 5: North America Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 6: North America Market Value (US$ Million) Forecast by Product, 2019 to 2034
Table 7: North America Market Value (US$ Million) Forecast by Test Type, 2019 to 2034
Table 8: North America Market Value (US$ Million) Forecast by Technology, 2019 to 2034
Table 9: Latin America Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 10: Latin America Market Value (US$ Million) Forecast by Product, 2019 to 2034
Table 11: Latin America Market Value (US$ Million) Forecast by Test Type, 2019 to 2034
Table 12: Latin America Market Value (US$ Million) Forecast by Technology, 2019 to 2034
Table 13: Western Europe Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 14: Western Europe Market Value (US$ Million) Forecast by Product, 2019 to 2034
Table 15: Western Europe Market Value (US$ Million) Forecast by Test Type, 2019 to 2034
Table 16: Western Europe Market Value (US$ Million) Forecast by Technology, 2019 to 2034
Table 17: Eastern Europe Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 18: Eastern Europe Market Value (US$ Million) Forecast by Product, 2019 to 2034
Table 19: Eastern Europe Market Value (US$ Million) Forecast by Test Type, 2019 to 2034
Table 20: Eastern Europe Market Value (US$ Million) Forecast by Technology, 2019 to 2034
Table 21: South Asia and Pacific Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 22: South Asia and Pacific Market Value (US$ Million) Forecast by Product, 2019 to 2034
Table 23: South Asia and Pacific Market Value (US$ Million) Forecast by Test Type, 2019 to 2034
Table 24: South Asia and Pacific Market Value (US$ Million) Forecast by Technology, 2019 to 2034
Table 25: East Asia Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 26: East Asia Market Value (US$ Million) Forecast by Product, 2019 to 2034
Table 27: East Asia Market Value (US$ Million) Forecast by Test Type, 2019 to 2034
Table 28: East Asia Market Value (US$ Million) Forecast by Technology, 2019 to 2034
Table 29: Middle East and Africa Market Value (US$ Million) Forecast by Country, 2019 to 2034
Table 30: Middle East and Africa Market Value (US$ Million) Forecast by Product, 2019 to 2034
Table 31: Middle East and Africa Market Value (US$ Million) Forecast by Test Type, 2019 to 2034
Table 32: Middle East and Africa Market Value (US$ Million) Forecast by Technology, 2019 to 2034
Figure 1: Global Market Value (US$ Million) by Product, 2024 to 2034
Figure 2: Global Market Value (US$ Million) by Test Type, 2024 to 2034
Figure 3: Global Market Value (US$ Million) by Technology, 2024 to 2034
Figure 4: Global Market Value (US$ Million) by Region, 2024 to 2034
Figure 5: Global Market Value (US$ Million) Analysis by Region, 2019 to 2034
Figure 6: Global Market Value Share (%) and BPS Analysis by Region, 2024 to 2034
Figure 7: Global Market Y-o-Y Growth (%) Projections by Region, 2024 to 2034
Figure 8: Global Market Value (US$ Million) Analysis by Product, 2019 to 2034
Figure 9: Global Market Value Share (%) and BPS Analysis by Product, 2024 to 2034
Figure 10: Global Market Y-o-Y Growth (%) Projections by Product, 2024 to 2034
Figure 11: Global Market Value (US$ Million) Analysis by Test Type, 2019 to 2034
Figure 12: Global Market Value Share (%) and BPS Analysis by Test Type, 2024 to 2034
Figure 13: Global Market Y-o-Y Growth (%) Projections by Test Type, 2024 to 2034
Figure 14: Global Market Value (US$ Million) Analysis by Technology, 2019 to 2034
Figure 15: Global Market Value Share (%) and BPS Analysis by Technology, 2024 to 2034
Figure 16: Global Market Y-o-Y Growth (%) Projections by Technology, 2024 to 2034
Figure 17: Global Market Attractiveness by Product, 2024 to 2034
Figure 18: Global Market Attractiveness by Test Type, 2024 to 2034
Figure 19: Global Market Attractiveness by Technology, 2024 to 2034
Figure 20: Global Market Attractiveness by Region, 2024 to 2034
Figure 21: North America Market Value (US$ Million) by Product, 2024 to 2034
Figure 22: North America Market Value (US$ Million) by Test Type, 2024 to 2034
Figure 23: North America Market Value (US$ Million) by Technology, 2024 to 2034
Figure 24: North America Market Value (US$ Million) by Country, 2024 to 2034
Figure 25: North America Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 26: North America Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 27: North America Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 28: North America Market Value (US$ Million) Analysis by Product, 2019 to 2034
Figure 29: North America Market Value Share (%) and BPS Analysis by Product, 2024 to 2034
Figure 30: North America Market Y-o-Y Growth (%) Projections by Product, 2024 to 2034
Figure 31: North America Market Value (US$ Million) Analysis by Test Type, 2019 to 2034
Figure 32: North America Market Value Share (%) and BPS Analysis by Test Type, 2024 to 2034
Figure 33: North America Market Y-o-Y Growth (%) Projections by Test Type, 2024 to 2034
Figure 34: North America Market Value (US$ Million) Analysis by Technology, 2019 to 2034
Figure 35: North America Market Value Share (%) and BPS Analysis by Technology, 2024 to 2034
Figure 36: North America Market Y-o-Y Growth (%) Projections by Technology, 2024 to 2034
Figure 37: North America Market Attractiveness by Product, 2024 to 2034
Figure 38: North America Market Attractiveness by Test Type, 2024 to 2034
Figure 39: North America Market Attractiveness by Technology, 2024 to 2034
Figure 40: North America Market Attractiveness by Country, 2024 to 2034
Figure 41: Latin America Market Value (US$ Million) by Product, 2024 to 2034
Figure 42: Latin America Market Value (US$ Million) by Test Type, 2024 to 2034
Figure 43: Latin America Market Value (US$ Million) by Technology, 2024 to 2034
Figure 44: Latin America Market Value (US$ Million) by Country, 2024 to 2034
Figure 45: Latin America Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 46: Latin America Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 47: Latin America Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 48: Latin America Market Value (US$ Million) Analysis by Product, 2019 to 2034
Figure 49: Latin America Market Value Share (%) and BPS Analysis by Product, 2024 to 2034
Figure 50: Latin America Market Y-o-Y Growth (%) Projections by Product, 2024 to 2034
Figure 51: Latin America Market Value (US$ Million) Analysis by Test Type, 2019 to 2034
Figure 52: Latin America Market Value Share (%) and BPS Analysis by Test Type, 2024 to 2034
Figure 53: Latin America Market Y-o-Y Growth (%) Projections by Test Type, 2024 to 2034
Figure 54: Latin America Market Value (US$ Million) Analysis by Technology, 2019 to 2034
Figure 55: Latin America Market Value Share (%) and BPS Analysis by Technology, 2024 to 2034
Figure 56: Latin America Market Y-o-Y Growth (%) Projections by Technology, 2024 to 2034
Figure 57: Latin America Market Attractiveness by Product, 2024 to 2034
Figure 58: Latin America Market Attractiveness by Test Type, 2024 to 2034
Figure 59: Latin America Market Attractiveness by Technology, 2024 to 2034
Figure 60: Latin America Market Attractiveness by Country, 2024 to 2034
Figure 61: Western Europe Market Value (US$ Million) by Product, 2024 to 2034
Figure 62: Western Europe Market Value (US$ Million) by Test Type, 2024 to 2034
Figure 63: Western Europe Market Value (US$ Million) by Technology, 2024 to 2034
Figure 64: Western Europe Market Value (US$ Million) by Country, 2024 to 2034
Figure 65: Western Europe Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 66: Western Europe Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 67: Western Europe Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 68: Western Europe Market Value (US$ Million) Analysis by Product, 2019 to 2034
Figure 69: Western Europe Market Value Share (%) and BPS Analysis by Product, 2024 to 2034
Figure 70: Western Europe Market Y-o-Y Growth (%) Projections by Product, 2024 to 2034
Figure 71: Western Europe Market Value (US$ Million) Analysis by Test Type, 2019 to 2034
Figure 72: Western Europe Market Value Share (%) and BPS Analysis by Test Type, 2024 to 2034
Figure 73: Western Europe Market Y-o-Y Growth (%) Projections by Test Type, 2024 to 2034
Figure 74: Western Europe Market Value (US$ Million) Analysis by Technology, 2019 to 2034
Figure 75: Western Europe Market Value Share (%) and BPS Analysis by Technology, 2024 to 2034
Figure 76: Western Europe Market Y-o-Y Growth (%) Projections by Technology, 2024 to 2034
Figure 77: Western Europe Market Attractiveness by Product, 2024 to 2034
Figure 78: Western Europe Market Attractiveness by Test Type, 2024 to 2034
Figure 79: Western Europe Market Attractiveness by Technology, 2024 to 2034
Figure 80: Western Europe Market Attractiveness by Country, 2024 to 2034
Figure 81: Eastern Europe Market Value (US$ Million) by Product, 2024 to 2034
Figure 82: Eastern Europe Market Value (US$ Million) by Test Type, 2024 to 2034
Figure 83: Eastern Europe Market Value (US$ Million) by Technology, 2024 to 2034
Figure 84: Eastern Europe Market Value (US$ Million) by Country, 2024 to 2034
Figure 85: Eastern Europe Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 86: Eastern Europe Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 87: Eastern Europe Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 88: Eastern Europe Market Value (US$ Million) Analysis by Product, 2019 to 2034
Figure 89: Eastern Europe Market Value Share (%) and BPS Analysis by Product, 2024 to 2034
Figure 90: Eastern Europe Market Y-o-Y Growth (%) Projections by Product, 2024 to 2034
Figure 91: Eastern Europe Market Value (US$ Million) Analysis by Test Type, 2019 to 2034
Figure 92: Eastern Europe Market Value Share (%) and BPS Analysis by Test Type, 2024 to 2034
Figure 93: Eastern Europe Market Y-o-Y Growth (%) Projections by Test Type, 2024 to 2034
Figure 94: Eastern Europe Market Value (US$ Million) Analysis by Technology, 2019 to 2034
Figure 95: Eastern Europe Market Value Share (%) and BPS Analysis by Technology, 2024 to 2034
Figure 96: Eastern Europe Market Y-o-Y Growth (%) Projections by Technology, 2024 to 2034
Figure 97: Eastern Europe Market Attractiveness by Product, 2024 to 2034
Figure 98: Eastern Europe Market Attractiveness by Test Type, 2024 to 2034
Figure 99: Eastern Europe Market Attractiveness by Technology, 2024 to 2034
Figure 100: Eastern Europe Market Attractiveness by Country, 2024 to 2034
Figure 101: South Asia and Pacific Market Value (US$ Million) by Product, 2024 to 2034
Figure 102: South Asia and Pacific Market Value (US$ Million) by Test Type, 2024 to 2034
Figure 103: South Asia and Pacific Market Value (US$ Million) by Technology, 2024 to 2034
Figure 104: South Asia and Pacific Market Value (US$ Million) by Country, 2024 to 2034
Figure 105: South Asia and Pacific Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 106: South Asia and Pacific Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 107: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 108: South Asia and Pacific Market Value (US$ Million) Analysis by Product, 2019 to 2034
Figure 109: South Asia and Pacific Market Value Share (%) and BPS Analysis by Product, 2024 to 2034
Figure 110: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Product, 2024 to 2034
Figure 111: South Asia and Pacific Market Value (US$ Million) Analysis by Test Type, 2019 to 2034
Figure 112: South Asia and Pacific Market Value Share (%) and BPS Analysis by Test Type, 2024 to 2034
Figure 113: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Test Type, 2024 to 2034
Figure 114: South Asia and Pacific Market Value (US$ Million) Analysis by Technology, 2019 to 2034
Figure 115: South Asia and Pacific Market Value Share (%) and BPS Analysis by Technology, 2024 to 2034
Figure 116: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Technology, 2024 to 2034
Figure 117: South Asia and Pacific Market Attractiveness by Product, 2024 to 2034
Figure 118: South Asia and Pacific Market Attractiveness by Test Type, 2024 to 2034
Figure 119: South Asia and Pacific Market Attractiveness by Technology, 2024 to 2034
Figure 120: South Asia and Pacific Market Attractiveness by Country, 2024 to 2034
Figure 121: East Asia Market Value (US$ Million) by Product, 2024 to 2034
Figure 122: East Asia Market Value (US$ Million) by Test Type, 2024 to 2034
Figure 123: East Asia Market Value (US$ Million) by Technology, 2024 to 2034
Figure 124: East Asia Market Value (US$ Million) by Country, 2024 to 2034
Figure 125: East Asia Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 126: East Asia Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 127: East Asia Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 128: East Asia Market Value (US$ Million) Analysis by Product, 2019 to 2034
Figure 129: East Asia Market Value Share (%) and BPS Analysis by Product, 2024 to 2034
Figure 130: East Asia Market Y-o-Y Growth (%) Projections by Product, 2024 to 2034
Figure 131: East Asia Market Value (US$ Million) Analysis by Test Type, 2019 to 2034
Figure 132: East Asia Market Value Share (%) and BPS Analysis by Test Type, 2024 to 2034
Figure 133: East Asia Market Y-o-Y Growth (%) Projections by Test Type, 2024 to 2034
Figure 134: East Asia Market Value (US$ Million) Analysis by Technology, 2019 to 2034
Figure 135: East Asia Market Value Share (%) and BPS Analysis by Technology, 2024 to 2034
Figure 136: East Asia Market Y-o-Y Growth (%) Projections by Technology, 2024 to 2034
Figure 137: East Asia Market Attractiveness by Product, 2024 to 2034
Figure 138: East Asia Market Attractiveness by Test Type, 2024 to 2034
Figure 139: East Asia Market Attractiveness by Technology, 2024 to 2034
Figure 140: East Asia Market Attractiveness by Country, 2024 to 2034
Figure 141: Middle East and Africa Market Value (US$ Million) by Product, 2024 to 2034
Figure 142: Middle East and Africa Market Value (US$ Million) by Test Type, 2024 to 2034
Figure 143: Middle East and Africa Market Value (US$ Million) by Technology, 2024 to 2034
Figure 144: Middle East and Africa Market Value (US$ Million) by Country, 2024 to 2034
Figure 145: Middle East and Africa Market Value (US$ Million) Analysis by Country, 2019 to 2034
Figure 146: Middle East and Africa Market Value Share (%) and BPS Analysis by Country, 2024 to 2034
Figure 147: Middle East and Africa Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 148: Middle East and Africa Market Value (US$ Million) Analysis by Product, 2019 to 2034
Figure 149: Middle East and Africa Market Value Share (%) and BPS Analysis by Product, 2024 to 2034
Figure 150: Middle East and Africa Market Y-o-Y Growth (%) Projections by Product, 2024 to 2034
Figure 151: Middle East and Africa Market Value (US$ Million) Analysis by Test Type, 2019 to 2034
Figure 152: Middle East and Africa Market Value Share (%) and BPS Analysis by Test Type, 2024 to 2034
Figure 153: Middle East and Africa Market Y-o-Y Growth (%) Projections by Test Type, 2024 to 2034
Figure 154: Middle East and Africa Market Value (US$ Million) Analysis by Technology, 2019 to 2034
Figure 155: Middle East and Africa Market Value Share (%) and BPS Analysis by Technology, 2024 to 2034
Figure 156: Middle East and Africa Market Y-o-Y Growth (%) Projections by Technology, 2024 to 2034
Figure 157: Middle East and Africa Market Attractiveness by Product, 2024 to 2034
Figure 158: Middle East and Africa Market Attractiveness by Test Type, 2024 to 2034
Figure 159: Middle East and Africa Market Attractiveness by Technology, 2024 to 2034
Figure 160: Middle East and Africa Market Attractiveness by Country, 2024 to 2034
The CTNG testing market is projected to reach a valuation of USD 1.8 Billion in 2024.
The CTNG testing industry is set to expand by a CAGR of 8.0% through 2034.
The CTNG testing market is forecast to reach USD 3.9 Billion by 2034.
Korea is expected to be the top performing market, exhibiting a CAGR of 9.8% through 2034.
Assays and kits segment is preferred, and is expected to account for a CAGR of 7.7% through 2034.
Explore In-vitro Diagnostics Devices Insights
CTNG Testing Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
